April 23, 2018 / 11:47 AM / a month ago

BRIEF-ProQR Provides Enrollment Update On QR-110 Clinical Trial

April 23 (Reuters) - ProQR Therapeutics NV:

* PROQR PROVIDES ENROLLMENT UPDATE ON QR-110 CLINICAL TRIAL AND HIGHLIGHTS OPHTHALMOLOGY PRESENTATIONS AT ARVO

* PROQR THERAPEUTICS NV - TRIAL IS ON TRACK TO ANNOUNCE INTERIM SIX-MONTH DATA ON SAFETY, EFFECTS ON VISION AND RETINAL STRUCTURE IN SECOND HALF OF YEAR

* PROQR THERAPEUTICS NV - ENROLLMENT IS ON TRACK IN ONGOING PHASE 1/2 CLINICAL TRIAL OF QR-110

* PROQR THERAPEUTICS NV - FULL TWELVE-MONTH TREATMENT DATA FROM ALL PATIENTS EXPECTED IN 2019 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below